Influence of uric acid and γ-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome

Nutrition

Volumn 24, Issue 7-8, 2008, Pages 675-681

  Simão, Andréa Name Colado ^a   Dichi, Jane Bandeira ^b   Barbosa, Décio Sabbatini ^a   Cecchini, Rubens ^b   Dichi, Isaias ^b  

^a University Hospital of Londrina   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Glutamyltransferase; Antioxidant defense; Metabolic syndrome; Oxidative stress; Uric acid

Indexed keywords

BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID HYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URIC ACID;

EID: 44749093098     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.03.021     Document Type: Article

References (41)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Lee K.-U. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 54 suppl 2 (2001) 29-33
3. Urakawa H., Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Noriko K., et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88 (2003) 4673-4676
4. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease?. The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
5. Menon V., Ram M., Dorn J., Armstrong D., Muti P., Freudenheim J.L., et al. Oxidative stress and glucose levels in a population-based sample. Diabet Med 21 (2004) 1346-1352
6. Nilsen O., Forde O.H., and Brenn T. The Tromso Heart Study: distribution and determinants of gamma-glutamyltransferase. Am J Epidemiol 32 (1990) 318-326
7. Wannamethee G., Ebrahin S., and Sharper A.G. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 42 (1995) 699-708
8. Perry I.J., Wannamethee S.G., and Sharper A.G. Prospective study of serum gamma-glutamyltransferase and risk of NIDMM. Diabetes Care 21 (1998) 732-737
9. Nannipieri M., Gonzales C., Baldi S., Posada R., Williams K., Haffner S.M., et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28 (2005) 1757-1762
10. Drozdz R., Parmentier C., Hachad H., Leroy P., Siest G., and Wellman M. Gamma-glutamyl transferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 25 (1998) 786-792
11. Strasak A.M., Rapp K., Hilbe W., Oberaigner W., Ruttmann E., Concin H., et al., VHM&PP Study Group. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 18 (2007) 1021-1029
12. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
13. Niskanen L.K., Laaksonen D.E., Nyyssonen K., Alfthan G., Lakka H.M., Lakka T.A., et al. Uric acid level as a risk for cardiovascular and all-mortality in middle-age men: a prospective cohort study. Arch Intern Med 164 (2004) 1546-1551
14. Molnár D., Decsil T., and Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obesity 28 (2004) 1197-1202
15. Jacobs Jr. D.R. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel III). JAMA 285 (2001) 2486-2497
16. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 (1997) 1087-1092
17. Repetto M., Reides C., Carretero M.L.G., Costa M., Griemberg G., and Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta 255 (1996) 107-117
18. Flecha B.G., Llesuy S., and Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10 (1991) 93-100
19. Jentzsch A.M., Bachmann H., Fürst P., and Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20 (1996) 251-256
20. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
21. Aruoma O.I., Akanmu D., Cecchini R., and Halliwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chem Biol Interact 77 (1991) 303-314
22. Shin M.-J., Park E., Lee J.H., and Chunga N. Relationship between insulin resistance and lipid peroxidation and antioxidant vitamins in hypercholesterolemic patients. Ann Nutr Metab 50 (2006) 115-120
23. Casado M.F., Cecchini A.L., Simão A.N.C., Oliveira R.D., and Cecchini R. Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol 45 (2007) 945-952
24. Cecchini R., Aruoma O.I., and Halliwell B. The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes or from DNA damage by bleomycin or o-phenanthrolene. Artefacts in the thiobarbituric acid test. Free Radic Res Commun 10 (1990) 245-258
25. Ames B.N., Cathcart R., Schwiers E., and Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78 (1981) 6858-6862
26. Maxwell S.R., Thomason H., Sandler D., LeGuen C., Baxter M.A., Thorpe G.H., et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27 (1997) 484-490
27. Halliwell B., and Gutteridge J.M.C. Antioxidant protection by compounds synthesized in vivo. 3rd ed. (1999), Oxford University Press, New York 19 197
28. Muscelli E., Natali A., Bianchi S., Bigazzi R., Galvan A.Q., Sironi A.M., et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 9 (1996) 746-752
29. Nakagawa T., Hu H., Zharikov S., Tutle K.R., Short R.A., Glushakova O., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290 (2006) F625-F631
30. Sautin Y.Y., Nakagawa T., Zharikov S., and Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293 (2007) C584-C596
31. Lee D.S., Evans J.C., Robins S.J., Wilson P.W., Albano I., Fox C.S., et al. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk. The Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
32. Kang Y.H., Min H.K., Son S.M., Kim I.J., and Kim Y.K. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 77 (2007) 306-313
33. Marchesini G., Brizi M., Bianvhini G., Tomassetti S., Bugianese E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
34. Lee D.H., Ha M.H., Kim J.H., Christiani D.C., Gross M.D., Steffes M., et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 43 (2003) 359-364
35. Zhang H., Liu H., Iies K.E., Liu R.M., Postlethwait E.M., Laperche Y., et al. 4-Hydroxynonenal induces rat γ-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol 34 (2006) 174-181
36. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535-539
37. Ikeda Y., Fujii J., Taniguchi N., and Meister A. Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc Natl Acad Sci U S A 92 (1995) 126-130
38. Joyce-Brady M., Jean J.C., and Hughey R.P. Gamma-glutamyl transferase and its isoform mediate an endoplasmatic reticulum stress response. J Biol Chem 276 (2001) 9468-9477
39. Stark A.A., Russel J.J., Langenbach R., Pagano D.A., Zeiger E., and Huberman E. Localization of oxidative damage by glutathione-gamma-glutamyl transpeptidase system in preneoplasic lesions in sections of liver from carcinogen-treated rats. Carcinogenesis 15 (1994) 343-348
40. Zalit I., Glass G.A., and Stark A.A. The role of chelators in the catalysis of glutathione-gamma glutamyl transpeptidase-dependent lipid peroxidation by transition metals. Biochem Mol Biol Int 40 (1996) 1123-1
41. Aruoma O.I., and Halliwell B. Inactivation of α1-antiproteinase by hydroxyl radicals. The effect of uric acid. FEBS Lett 244 (1989) 76-80